Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
Clicks: 159
ID: 270100
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
159 views
15 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #56 of 95 articles by views in acta neuropathologica communications
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Alpha-synuclein (α-syn) aggregation is the hallmark pathological lesion in brains of patients with Parkinson’s disease (PD) and related neurological disorders characterized as synucleinopathies. Accumulating evidence now indicates that ...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (29 words).
Try re-searching for a better abstract.
| Reference Key |
hallbeck2021actaaccumulation
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Juan F. Reyes, Sara Ekmark-Léwen, Marina Perdiki, Therése Klingstedt, Alana Hoffmann, Emilia Wiechec, Per Nilsson, K. Peter R. Nilsson, Irina Alafuzoff, Martin Ingelsson, Martin Hallbeck;Juan F. Reyes;Sara Ekmark-Léwen;Marina Perdiki;Therése Klingstedt;Alana Hoffmann;Emilia Wiechec;Per Nilsson;K. Peter R. Nilsson;Irina Alafuzoff;Martin Ingelsson;Martin Hallbeck; |
| Journal | acta neuropathologica communications |
| Year | 2021 |
| DOI |
10.1186/s40478-021-01136-3
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.